AdvanSix Reports Q4 Revenue of $359.95M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 20 2026
0mins
Should l Buy ASIX?
Reports Q4 revenue $359.95M vs. $329.06M last year. "The AdvanSix team executed well to close out 2025. We delivered full year Adjusted EBITDA of $157 million and generated positive free cash flow in a year characterized by continued cyclical trough market conditions for Nylon Solutions, robust Plant Nutrients supply and demand fundamentals amid a higher raw material input cost environment, and mixed Chemical Intermediates industry conditions with lower net pricing as anticipated," said Erin Kane, president and CEO of AdvanSix. "We generated these results while successfully executing our planned plant turnarounds, delivering record annual production across both of our key ammonia and sulfuric acid unit operations, funding key growth and enterprise initiatives including our SUSTAIN program, claiming additional 45Q carbon capture tax credits, receiving final settlement proceeds related to the 2019 PES supplier shutdown claim, preserving our competitive dividend and maintaining conservative debt leverage levels."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ASIX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ASIX
Wall Street analysts forecast ASIX stock price to rise
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 18.350
Low
19.00
Averages
19.00
High
19.00
Current: 18.350
Low
19.00
Averages
19.00
High
19.00
About ASIX
AdvanSix Inc. is a diversified chemistry company that produces essential materials for its customers in a variety of end markets and applications, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. Its product lines include nylon solutions, plant nutrients, and chemical intermediates. It sells its Nylon 6 resin globally, under the Aegis brand name. It markets and sells ammonium sulfate to North American and South American distributors, farm cooperatives and retailers to fertilize crops. It also manufactures sulfuric acid, ammonia and carbon dioxide. It manufactures, markets and sells a number of chemical intermediate products. Its other intermediate chemicals include phenol, alpha-methyl styrene (AMS), cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines. Additional end-products for intermediates include automotive components, and water treatment and pharmaceutical intermediates.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
AdvanSix Q4 2025 Earnings Call Insights
- Strong Financial Performance: AdvanSix reported $360 million in sales for Q4 2025, reflecting a 9% year-over-year increase, with an 11% rise in sales volume, indicating the company's resilience and growth potential amid market fluctuations.
- Adjusted EBITDA Growth: The company achieved an adjusted EBITDA of $25 million, up $15 million from last year, with an EBITDA margin of 6.9%, showcasing success in cost control and operational efficiency improvements.
- Capital Expenditure Plans: Projected capital expenditures for 2026 are between $75 million and $95 million, reduced from $116 million in 2025, indicating a cautious approach to base investments based on risk assessments.
- Cost Savings Initiatives: The company initiated a non-manpower fixed cost takeout initiative targeting $30 million in annual run rate savings, aimed at enhancing operational efficiency through recent ERP upgrades and improved analytics tools.
See More
AdvanSix Declares Quarterly Dividend of $0.16
- Quarterly Dividend Declaration: AdvanSix has declared a quarterly dividend of $0.16 per share, consistent with previous distributions, indicating the company's ongoing ability to maintain stable cash flows despite cautious market sentiment regarding future growth.
- Dividend Yield: The forward yield of 3.43% provides investors with a relatively stable return, reflecting the company's financial health in the current economic environment, which is crucial for attracting and retaining shareholders.
- Payment Schedule: The dividend will be payable on March 23, with a record date of March 9 and an ex-dividend date also on March 9, ensuring that shareholders receive their earnings promptly, which enhances investor confidence in the company.
- Performance Highlights: AdvanSix exceeded both top-line and bottom-line estimates, demonstrating resilience despite facing challenges, and has initiated a fiscal year 2026 outlook, signaling a positive attitude towards future growth opportunities.
See More
AdvanSix Q4 Earnings Beat Expectations
- Earnings Beat: AdvanSix reported a Q4 non-GAAP EPS of $0.03, exceeding expectations by $0.09, indicating an improvement in profitability despite ongoing market challenges.
- Revenue Growth: The company achieved Q4 revenue of $359.94 million, a 9.4% year-over-year increase, surpassing market expectations by $19.09 million, reflecting strong demand for its products and driving sales growth.
- Cash Flow Improvement: Q4 cash flow from operations reached $64 million, demonstrating successful completion of planned plant turnarounds for 2025, with positive progress in cost control expected to enhance cash flow in 2026.
- Capital Expenditure Plans: Expected capital expenditures for 2026 are projected between $75 million and $95 million, down from approximately $116 million in 2025, indicating a risk-based prioritization of investments aimed at supporting ongoing growth initiatives.
See More
AdvanSix Reports Strong Financial Results for 2025
- Strong Annual Performance: AdvanSix reported $1.522 billion in sales for 2025, a slight increase of 0.4% from 2024, with a net income of $49.3 million, demonstrating the company's resilience and growth potential in a dynamic industry environment.
- Adjusted EBITDA Growth: The adjusted EBITDA for 2025 reached $156.8 million, reflecting a 10.2% increase from 2024, with an adjusted EBITDA margin rising to 10.3%, indicating successful cost control and operational efficiency improvements.
- Quarterly Sales Increase: In Q4 2025, sales amounted to $359.9 million, representing a year-over-year growth of approximately 9%, primarily driven by strong demand for plant nutrients and improved market pricing, despite a decline in chemical intermediates pricing.
- Cash Flow and Dividends: The company generated $36.1 million in free cash flow in Q4, showcasing robust cash generation capabilities, while declaring a quarterly cash dividend of $0.16 per share, underscoring its commitment to shareholder returns.
See More
AdvanSix Reports Strong 2025 Financial Results with Improved Cash Flow
- Sales Growth: In Q4 2025, AdvanSix reported sales of $360 million, a 9% increase year-over-year, primarily driven by an 11% rise in sales volume, demonstrating the company's resilience and growth potential amid market fluctuations.
- Profitability Improvement: The adjusted earnings per share for 2025 was $0.03, down $0.06 from the previous year; however, the company achieved an adjusted EBITDA of $24.8 million, a $14.5 million increase year-over-year, driven by successful plant turnarounds and cost control measures.
- Cash Flow Performance: Operating cash flow for Q4 was $63.7 million, slightly down from the previous year, yet it reflects the company's ability to generate cash in challenging market conditions, with expectations for further cash flow improvement in 2026.
- Strategic Investment: The company plans to limit capital expenditures to between $75 million and $95 million in 2026, reflecting a risk-based prioritization and continued investment in growth projects aimed at enhancing long-term competitiveness.
See More
Advansix Reports Q4 Sales of $359.947 Million
- Sales Performance: ADVANSix reported Q4 sales of USD 359.947 million.
- Financial Overview: The sales figure reflects the company's performance in the fourth quarter of the fiscal year.
See More
AdvanSix Q4 2025 Earnings Call Insights
- Strong Financial Performance: AdvanSix reported $360 million in sales for Q4 2025, reflecting a 9% year-over-year increase, with an 11% rise in sales volume, indicating the company's resilience and growth potential amid market fluctuations.
- Adjusted EBITDA Growth: The company achieved an adjusted EBITDA of $25 million, up $15 million from last year, with an EBITDA margin of 6.9%, showcasing success in cost control and operational efficiency improvements.
- Capital Expenditure Plans: Projected capital expenditures for 2026 are between $75 million and $95 million, reduced from $116 million in 2025, indicating a cautious approach to base investments based on risk assessments.
- Cost Savings Initiatives: The company initiated a non-manpower fixed cost takeout initiative targeting $30 million in annual run rate savings, aimed at enhancing operational efficiency through recent ERP upgrades and improved analytics tools.
See More
AdvanSix Declares Quarterly Dividend of $0.16
- Quarterly Dividend Declaration: AdvanSix has declared a quarterly dividend of $0.16 per share, consistent with previous distributions, indicating the company's ongoing ability to maintain stable cash flows despite cautious market sentiment regarding future growth.
- Dividend Yield: The forward yield of 3.43% provides investors with a relatively stable return, reflecting the company's financial health in the current economic environment, which is crucial for attracting and retaining shareholders.
- Payment Schedule: The dividend will be payable on March 23, with a record date of March 9 and an ex-dividend date also on March 9, ensuring that shareholders receive their earnings promptly, which enhances investor confidence in the company.
- Performance Highlights: AdvanSix exceeded both top-line and bottom-line estimates, demonstrating resilience despite facing challenges, and has initiated a fiscal year 2026 outlook, signaling a positive attitude towards future growth opportunities.
See More
AdvanSix Q4 Earnings Beat Expectations
- Earnings Beat: AdvanSix reported a Q4 non-GAAP EPS of $0.03, exceeding expectations by $0.09, indicating an improvement in profitability despite ongoing market challenges.
- Revenue Growth: The company achieved Q4 revenue of $359.94 million, a 9.4% year-over-year increase, surpassing market expectations by $19.09 million, reflecting strong demand for its products and driving sales growth.
- Cash Flow Improvement: Q4 cash flow from operations reached $64 million, demonstrating successful completion of planned plant turnarounds for 2025, with positive progress in cost control expected to enhance cash flow in 2026.
- Capital Expenditure Plans: Expected capital expenditures for 2026 are projected between $75 million and $95 million, down from approximately $116 million in 2025, indicating a risk-based prioritization of investments aimed at supporting ongoing growth initiatives.
See More
AdvanSix Reports Strong Financial Results for 2025
- Strong Annual Performance: AdvanSix reported $1.522 billion in sales for 2025, a slight increase of 0.4% from 2024, with a net income of $49.3 million, demonstrating the company's resilience and growth potential in a dynamic industry environment.
- Adjusted EBITDA Growth: The adjusted EBITDA for 2025 reached $156.8 million, reflecting a 10.2% increase from 2024, with an adjusted EBITDA margin rising to 10.3%, indicating successful cost control and operational efficiency improvements.
- Quarterly Sales Increase: In Q4 2025, sales amounted to $359.9 million, representing a year-over-year growth of approximately 9%, primarily driven by strong demand for plant nutrients and improved market pricing, despite a decline in chemical intermediates pricing.
- Cash Flow and Dividends: The company generated $36.1 million in free cash flow in Q4, showcasing robust cash generation capabilities, while declaring a quarterly cash dividend of $0.16 per share, underscoring its commitment to shareholder returns.
See More
AdvanSix Reports Strong 2025 Financial Results with Improved Cash Flow
- Sales Growth: In Q4 2025, AdvanSix reported sales of $360 million, a 9% increase year-over-year, primarily driven by an 11% rise in sales volume, demonstrating the company's resilience and growth potential amid market fluctuations.
- Profitability Improvement: The adjusted earnings per share for 2025 was $0.03, down $0.06 from the previous year; however, the company achieved an adjusted EBITDA of $24.8 million, a $14.5 million increase year-over-year, driven by successful plant turnarounds and cost control measures.
- Cash Flow Performance: Operating cash flow for Q4 was $63.7 million, slightly down from the previous year, yet it reflects the company's ability to generate cash in challenging market conditions, with expectations for further cash flow improvement in 2026.
- Strategic Investment: The company plans to limit capital expenditures to between $75 million and $95 million in 2026, reflecting a risk-based prioritization and continued investment in growth projects aimed at enhancing long-term competitiveness.
See More
Advansix Reports Q4 Sales of $359.947 Million
- Sales Performance: ADVANSix reported Q4 sales of USD 359.947 million.
- Financial Overview: The sales figure reflects the company's performance in the fourth quarter of the fiscal year.
See More
